[at noodls] – ; Termination of At the Market (ATM) Equity Offering Program; and Execution of Term Sheet for Debt Financing IRVINGTON, N.Y., Feb. 12, 2013 (GLOBE NEWSWIRE) – MELA Sciences, Inc. (Nasdaq:MELA), the medical … moreView todays social media effects on MELAView the latest stocks trending across Twitter. Click to view dashboardSee who MELA is hiring next, click here […]
[at noodls] – MELA Sciences to Release Fourth Quarter and Year End 2012 Financial Results and Host Conference Call on Tuesday, March 5, 2013 IRVINGTON, NY, February 4, 2013 – MELA Sciences, Inc.(NASDAQ: MELA), the medical … moreView todays social media effects on MELAView the latest stocks trending across Twitter. Click to view dashboardSee who MELA is hiring next, click […]
[at noodls] – Spotting skin cancer in the Sunshine State just got a little easier. A new 3D tool is helping one local dermatologist screen for the deadliest form of cancer, pain free. Read…This is an abstract of the … moreView todays social media effects on MELAView the latest stocks trending across Twitter. Click to view dashboardSee who MELA is […]
[at noodls] – IRVINGTON, NY, January 4, 2013 – MELA Sciences, Inc.(NASDAQ: MELA), the medical device company that has developed MelaFind®, today announced that it will be participating in the upcoming Needham Growth … moreView todays social media effects on MELAView the latest stocks trending across Twitter. Click to view dashboardSee who MELA is hiring next, click here to view […]
[at noodls] – NEW YORK, NY, January 3, 2013 – MELA Sciences, Inc.(NASDAQ: MELA), the medical device company that developed MelaFind®, a breakthrough device intended to help dermatologists detect melanoma when it is … moreView todays social media effects on MELAView the latest stocks trending across Twitter. Click to view dashboardSee who MELA is hiring next, click here to view […]
[at noodls] – Criteria for inclusion are significant clinical impact, high probability of commercial success, and significant human interest NEW YORK, NY, November 5, 2012 – MELA Sciences, Inc. (NASDAQ: MELA), the medical … moreView todays social media effects on MELAView the latest stocks trending across Twitter. Click to view dashboard […]
